Cheers, Mega.
I guess I was sailing close to the "Off-topic" wind, though perhaps HC's being a bit precious.
Anyway, like CRISPR, CAR-T technology is self-evidently the way of the future, and the Australian listed offerings are limited to CHM and PTX.
Some world-class research - and wonderful opportunity - bundled in there though.
IPO - Chimeric Therapeutics Limited - 18 January 2021 #, page-102
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.450M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $16.10K | 2.542M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 19709869 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 7657259 | 10 |
View Market Depth
| Last trade - 16.10pm 10/01/2025 (20 minute delay) ? |
| CHM (ASX) Chart |
